Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Thurs Jan 9th, the US Stock Markets will be closed in observance of a national day of mourning for former President Jimmy Carter. Read the press release here. Regular trading hours will resume tomorrow.

Medicinova Inc (MNOV)

Medicinova Inc (MNOV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
MediciNova, Inc. Announces Interim Analysis Results from COMBAT-ALS Trial of MN-166 at International Symposium on ALS/MND

MediciNova presents interim results from COMBAT-ALS trial of MN-166 for ALS at an international symposium.Quiver AI SummaryMediciNova, Inc. announced that interim analysis results from its Phase 2b/3 COMBAT-ALS...

MNOV : 1.9900 (-5.24%)
MediciNova Presents Study Update and Interim Analysis of Phase 2/3 Clinical Trial of MN-166 (ibudilast) in ALS (COMBAT-ALS Clinical Trial) at the 35th International Symposium on ALS/MND

MNOV : 1.9900 (-5.24%)
MediciNova, Inc. Provides Corporate Update and Highlights Ongoing Clinical Trials for MN166 and Other Programs

MediciNova updates shareholders on clinical trials and strategic collaborations for neurodegenerative diseases and inflammatory conditions.Quiver AI SummaryMediciNova, Inc., a biopharmaceutical company...

MNOV : 1.9900 (-5.24%)
MediciNova CEO Yuichi Iwaki Provides Corporate Update in Letter to Stockholders

MNOV : 1.9900 (-5.24%)
MediciNova, Inc. Receives Notice of Allowance for Patent on MN-001 Method to Decrease Triglyceride Synthesis in the Liver

MediciNova announces patent allowance for MN-001, a method to reduce liver triglyceride synthesis, aiding metabolic disorder treatments.Quiver AI SummaryMediciNova, Inc. has announced that it received...

MNOV : 1.9900 (-5.24%)
MediciNova Receives Notice of Allowance from United States Patent and Trademark Office for New Patent Covering MN-001 for Triglyceride Synthesis in the Liver

MNOV : 1.9900 (-5.24%)
MediciNova: Q3 Earnings Snapshot

MediciNova: Q3 Earnings Snapshot

MNOV : 1.9900 (-5.24%)
10 Stocks Retailers Are Most Bullish/Bearish About On Tuesday

Earnings have largely impacted sentiment toward stocks that made it to the most bullish and bearish lists on Stocktwits Tuesday.

ALDX : 5.11 (unch)
STIM : 1.5000 (-2.60%)
PGY : 9.08 (-7.06%)
QSI : 2.64 (-24.46%)
MNOV : 1.9900 (-5.24%)
AXSM : 82.57 (-1.44%)
VSAT : 8.99 (-6.94%)
ZS : 187.28 (+1.84%)
BTM : 1.5700 (-1.87%)
RVPH : 1.8700 (-6.50%)
SPY : 589.49 (+0.15%)
XBI : 92.31 (-0.60%)
MediciNova Given Notice of Monetary Damages Due Under Patent Settlement of Sanofi-Novartis

MNOV : 1.9900 (-5.24%)
MediciNova Announces Update of Phase 2/3 Clinical Trial of MN-166 (ibudilast) in ALS patients (COMBAT-ALS) at the 2024 Annual NEALS Meeting (Northeast Amyotrophic Lateral Sclerosis Consortium)

MNOV : 1.9900 (-5.24%)

Barchart Exclusives

What Market Looks "Best"?
I was asked what my "favorite" market is heading into 2025. My answer was what it has been for the past two decades - Corn. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar